Surfactant alterations and treatment of lung transplant ischemia–reperfusion injury

References

• Hosenpud JD, Bennett LE, Keck BM, Boucek MM, Novick RJ. The registry of the international society for heart and lung transplantation: seventeenth official report-2000. J Heart Lung Transplant 2000; 19: 909–31
   PubMed Web of Science ®Google Scholar
• De Perrot M, Liu M, Waddell TK, Keshavjee S. Ischemia-reperfusion-induced lung injury. Am J Respir Crit Care Med 2003; 167: 490–511
   PubMed Web of Science ®Google Scholar
• Fiser SM, Tribble CG, Long SM, Kaza AK, Kern JA, Jones DR, et al. Ischemia-reperfusion injury after lung transplantation increases risk of late bronchiolitis obliterans syndrome. Ann Thorac Surg 2002; 73: 1041–7–discussion 1047–8
   Google Scholar
• Thabut G, Mal H, Cerrina J, Dartevelle P, Dromer C, Velly JF, et al. Graft ischemic time and outcome of lung transplantation: a multicenter analysis. Am J Respir Crit Care Med 2005; 171: 786–91
   PubMed Web of Science ®Google Scholar
• Khan SU, Salloum J, O'Donovan PB, Mascha EJ, Mehta AC, Matthay MA, et al. Acute pulmonary edema after lung transplantation: the pulmonary reimplantation response. Chest 1999; 116: 187–94
   PubMedGoogle Scholar
• Hohlfeld JM, Tiryaki E, Hamm H, Hoymann HG, Krug N, Haverich A, et al. Pulmonary surfactant activity is impaired in lung transplant recipients. Am J Respir Crit Care Med 1998; 158: 706–12
   PubMedGoogle Scholar
• Veldhuizen RA, Lee J, Sandler D, Hull W, Whitsett JA, Lewis J, et al. Alterations in pulmonary surfactant composition and activity after experimental lung transplantation. Am Rev Respir Dis 1993; 148: 208–15
   PubMed Web of Science ®Google Scholar
• Erasmus ME, Petersen AH, Oetomo SB, Prop J. The function of surfactant is impaired during the reimplantation response in rat lung transplants. J Heart Lung Transplant 1994; 13: 791–802
   PubMed Web of Science ®Google Scholar
• Novick RJ, Veldhuizen RA, Possmayer F, Lee J, Sandler D, Lewis JF. Exogenous surfactant therapy in thirty-eight hour lung graft preservation for transplantation. J Thorac Cardiovasc Surg 1994; 108: 259–68
   PubMedGoogle Scholar
• Van der Kaaij NP, Haitsma JJ, Kluin J, Lambrecht BN, Lachmann B, de Bruin RW, et al. Surfactant pretreatment ameliorates ischemia-reperfusion injury of the lung. Eur J Cardiothorac Surg 2005; 27: 774–82
   PubMedGoogle Scholar
• King RC, Binns OA, Rodriguez F, Kanithanon RC, Daniel TM, Spotnitz WD, et al. Reperfusion injury significantly impacts clinical outcome after pulmonary transplantation. Ann Thorac Surg 2000; 69: 1681–5
   PubMed Web of Science ®Google Scholar
• Haitsma JJ, Papadakos PJ, Lachmann B. Surfactant therapy for acute lung injury/acute respiratory distress syndrome. Curr Opin Crit Care 2004; 10: 18–22
   PubMedGoogle Scholar
• Boehler A, Kesten S, Weder W, Speich R. Bronchiolitis obliterans after lung transplantation: a review. Chest 1998; 114: 1411–26
   PubMed Web of Science ®Google Scholar
• Tullius SG, Tilney NL. Both alloantigen-dependent and -independent factors influence chronic allograft rejection. Transplantation 1995; 59: 313–8
   PubMed Web of Science ®Google Scholar
• Grace PA, Mathie RT. Ischaemia-reperfusion-injury. Blackwell Science Ltd, OxfordUK 1999
   Google Scholar
• Krishnadasan B, Naidu B, Rosengart M, Farr AL, Barnes A, Verrier ED, et al. Decreased lung ischemia-reperfusion injury in rats after preoperative administration of cyclosporine and tacrolimus. J Thorac Cardiovasc Surg 2002; 123: 756–67
   PubMed Web of Science ®Google Scholar
• Takeyoshi I, Otani Y, Koibuchi Y, Yokoe T, Iino Y, Matsumoto K, et al. Effects of FR167653 on pulmonary ischemia-reperfusion injury: administration timing. Transplant Proc 1999; 31: 1935–6
   PubMedGoogle Scholar
• De Perrot M, Imai Y, Volgyesi GA, Waddell TK, Liu M, Mullen JB, et al. Effect of ventilator-induced lung injury on the development of reperfusion injury in a rat lung transplant model. J Thorac Cardiovasc Surg 2002; 124: 1137–44
   PubMedGoogle Scholar
• Griese M. Pulmonary surfactant in health and human lung diseases: state of the art. Eur Respir J 1999; 13: 1455–76
   PubMed Web of Science ®Google Scholar
• Haitsma JJ, Lachmann RA, Lachmann B. Lung protective ventilation in ARDS: role of mediators, PEEP and surfactant. Monaldi Arch Chest Dis 2003; 59: 108–18
   PubMedGoogle Scholar
• Ochs M, Nenadic I, Fehrenbach A, Albes JM, Wahlers T, Richter J, et al. Ultrastructural alterations in intraalveolar surfactant subtypes after experimental ischemia and reperfusion. Am J Respir Crit Care Med 1999; 160: 718–24
   PubMed Web of Science ®Google Scholar
• Gunther A, Balser M, Schmidt R, Markart P, Olk A, Borgermann J, et al. Surfactant abnormalities after single lung transplantation in dogs: impact of bronchoscopic surfactant administration. J Thorac Cardiovasc Surg 2004; 127: 344–54
   PubMed Web of Science ®Google Scholar
• Semik M, Schnabel R, Bruske T, Lange V, Wottge H, Morgenrot K, et al. Ultrastructural studies of acute rejection following single lung transplantation in the rat—histological and immunohistological findings. Thorac Cardiovasc Surg 1994; 42: 290–7
   PubMedGoogle Scholar
• Erasmus ME, Hofstede GJ, Petersen AH, Batenburg JJ, Haagsman HP, Oetomo SB, et al. SP-A-enriched surfactant for treatment of rat lung transplants with SP-A deficiency after storage and reperfusion. Transplantation 2002; 73: 348–52
   PubMedGoogle Scholar
• Klepetko W, Lohninger A, Wisser W, Mueller MR, Khunl-Brady G, Windisch A, et al. Pulmonary surfactant in bronchoalveolar lavage after canine lung transplantation: effect of L-carnitine application. J Thorac Cardiovasc Surg 1990; 99: 1048–58
   PubMedGoogle Scholar
• Erasmus ME, Petersen AH, Hofstede G, Haagsman HP, Bambang Oetomo S, Prop J. Surfactant treatment before reperfusion improves the immediate function of lung transplants in rats. Am J Respir Crit Care Med 1996; 153: 665–70
   PubMedGoogle Scholar
• Novick RJ, Gilpin AA, Gehman KE, Ali IS, Veldhuizen RA, Duplan J, et al. Mitigation of injury in canine lung grafts by exogenous surfactant therapy. J Thorac Cardiovasc Surg 1997; 113: 342–53
   PubMed Web of Science ®Google Scholar
• Friedrich I, Borgermann J, Splittgerber FH, Brinkmann M, Reidemeister JC, Silber RE, et al. Bronchoscopic surfactant administration preserves gas exchange and pulmonary compliance after single lung transplantation in dogs. J Thorac Cardiovasc Surg 2004; 127: 335–43
   PubMedGoogle Scholar
• Warnecke G, Struber M, Fraud S, Hohlfeld JM, Haverich A. Combined exogenous surfactant and inhaled nitric oxide therapy for lung ischemia-reperfusion injury in minipigs. Transplantation 2001; 71: 1238–44
   PubMedGoogle Scholar
• Andrade RS, Solien EE, Wangensteen OD, Tsai MY, Kshettry VR, Bolman RM 3rd. Surfactant dysfunction in lung preservation. Transplantation 1995; 60: 536–41
   PubMed Web of Science ®Google Scholar
• Andrade RS, Wangensteen OD, Jo JK, Tsai MY, Bolman RM 3rd. Effect of hypothermic pulmonary artery flushing on capillary filtration coefficient. Transplantation 2000; 70: 267–71
   PubMedGoogle Scholar
• Struber M, McGregor CG, Locke TJ, Miller VM. Effect of flush-perfusion with Euro-Collins solution on pulmonary arterial function. Transplant Proc 1990; 22: 2206–11
   PubMedGoogle Scholar
• Struber M, Ehlers KA, Nilsson FN, Miller VM, McGregor CG, Haverich A. Effects of lung preservation with Euro-Collins and University of Wisconsin solutions on endothelium-dependent relaxations. Ann Thorac Surg 1997; 63: 1428–35
   PubMedGoogle Scholar
• Struber M, Hohlfeld JM, Fraund S, Kim P, Warnecke G, Haverich A. Low-potassium dextran solution ameliorates reperfusion injury of the lung and protects surfactant function. J Thorac Cardiovasc Surg 2000; 120: 566–72
   PubMedGoogle Scholar
• Struber M, Hohlfeld JM, Kofidis T, Warnecke G, Niedermeyer J, Sommer SP, et al. Surfactant function in lung transplantation after 24 hours of ischemia: advantage of retrograde flush perfusion for preservation. J Thorac Cardiovasc Surg 2002; 123: 98–103
   PubMedGoogle Scholar
• Lachmann B, Eijking EP, So KL, Gommers D. In vivo evaluation of the inhibitory capacity of human plasma on exogenous surfactant function. Intensive Care Med 1994; 20: 6–11
   PubMed Web of Science ®Google Scholar
• Cockshutt AM, Weitz J, Possmayer F. Pulmonary surfactant-associated protein A enhances the surface activity of lipid extract surfactant and reverses inhibition by blood proteins in vitro. Biochemistry 1990; 29: 8424–9
   PubMed Web of Science ®Google Scholar
• Erasmus ME, Hofstede GJ, Petersen AH, Haagsman HP, Oetomo SB, Prop J. Effects of early surfactant treatment persisting for one week after lung transplantation in rats. Am J Respir Crit Care Med 1997; 156: 567–72
   PubMedGoogle Scholar
• Hohlfeld JM, Struber M, Ahlf K, Hoeper MM, Fraund S, Krug N, et al. Exogenous surfactant improves survival and surfactant function in ischaemia-reperfusion injury in minipigs. Eur Respir J 1999; 13: 1037–43
   PubMedGoogle Scholar
• Struber M, Cremer J, Harringer W, Hirt SW, Costard-Jackle A, Haverich A. Nebulized synthetic surfactant in reperfusion injury after single lung transplantation. J Thorac Cardiovasc Surg 1995; 110: 563–4
   PubMedGoogle Scholar
• Struber M, Hirt SW, Cremer J, Harringer W, Haverich A. Surfactant replacement in reperfusion injury after clinical lung transplantation. Intensive Care Med 1999; 25: 862–4
   PubMedGoogle Scholar
• Struber M, Wilhelmi M, Harringer W, Niedermeyer J, Anssar M, Kunsebeck A, et al. Flush perfusion with low potassium dextran solution improves early graft function in clinical lung transplantation. Eur J Cardiothorac Surg 2001; 19: 190–4
   PubMed Web of Science ®Google Scholar
• Novick RJ, MacDonald J, Veldhuizen RA, Wan F, Duplan J, Denning L, et al. Evaluation of surfactant treatment strategies after prolonged graft storage in lung transplantation. Am J Respir Crit Care Med 1996; 154: 98–104
   PubMed Web of Science ®Google Scholar
• Hausen B, Rohde R, Hewitt CW, Schroeder F, Beuke M, Ramsamooj R, et al. Exogenous surfactant treatment before and after sixteen hours of ischemia in experimental lung transplantation. J Thorac Cardiovasc Surg 1997; 113: 1050–8
   PubMedGoogle Scholar
• Koletsis E, Chatzimichalis A, Fotopoulos V, Kokkinis K, Papadimitriou E, Tiniakos D, et al. Donor lung pretreatment with surfactant in experimental transplantation preserves graft hemodynamics and alveolar morphology. Exp Biol Med (Maywood) 2003; 228: 540–5
   PubMedGoogle Scholar
• Thomassen MJ, Meeker DP, Antal JM, Connors MJ, Wiedemann HP. Synthetic surfactant (Exosurf) inhibits endotoxin-stimulated cytokine secretion by human alveolar macrophages. Am J Respir Cell Mol Biol 1992; 7: 257–60
   PubMed Web of Science ®Google Scholar
• Speer CP, Gotze B, Curstedt T, Robertson B. Phagocytic functions and tumor necrosis factor secretion of human monocytes exposed to natural porcine surfactant (Curosurf). Pediatr Res 1991; 30: 69–74
   PubMed Web of Science ®Google Scholar
• Matalon S, Holm BA, Baker RR, Whitfield MK, Freeman BA. Characterization of antioxidant activities of pulmonary surfactant mixtures. Biochim Biophys Acta 1990; 1035: 121–7
   PubMed Web of Science ®Google Scholar
• Casals C, Varela A, Ruano ML, Valino F, Perez-Gil J, Torre N, et al. Increase of C-reactive protein and decrease of surfactant protein a in surfactant after lung transplantation. Am J Respir Crit Care Med 1998; 157: 43–9
   PubMed Web of Science ®Google Scholar
• Buchanan SA, Mauney MC, Parekh VI, DeLima NF, Binns OA, Cope JT, et al. Intratracheal surfactant administration preserves airway compliance during lung reperfusion. Ann Thorac Surg 1996; 62: 1617–21
   PubMedGoogle Scholar
• Novick RJ, Gehman KE, Ali IS, Lee J. Lung preservation: the importance of endothelial and alveolar type II cell integrity. Ann Thorac Surg 1996; 62: 302–14
   PubMed Web of Science ®Google Scholar